Cosmos Health Company Leadership
| COSM Stock | USD 0.81 0.02 2.53% |
Cosmos Health employs about 123 people. The company is managed by 5 executives with a total tenure of roughly 18 years, averaging almost 3.0 years of service per executive, having 24.6 employees per reported executive. Analysis of Cosmos Health's management performance can provide insight into the firm performance.
| Grigorios Siokas Chairman Chairman of the Board, CEO, CFO |
Cosmos |
Cosmos Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.2023) % which means that it has lost $0.2023 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5661) %, meaning that it created substantial loss on money invested by shareholders. Cosmos Health's management efficiency ratios could be used to measure how well Cosmos Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.33. In addition to that, Return On Capital Employed is likely to grow to -0.5. At this time, Cosmos Health's Asset Turnover is very stable compared to the past year.As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 16.7 M, though Net Loss is likely to grow to (13.3 M).
Cosmos Health Workforce Comparison
Cosmos Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 29,254. Cosmos Health adds roughly 123 in number of employees claiming only tiny portion of equities under Health Care industry.
Cosmos Health Profit Margins
The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0774 | 0.0815 |
|
|
Cosmos Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cosmos Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cosmos Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cosmos Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Grigorios Siokas over two months ago Disposition of 42500 shares by Grigorios Siokas of Cosmos Health at 0.28 subject to Rule 16b-3 | ||
Grigorios Siokas over six months ago Disposition of 4500 shares by Grigorios Siokas of Cosmos Health at 0.26 subject to Rule 16b-3 | ||
Grigorios Siokas over six months ago Disposition of 150000 shares by Grigorios Siokas of Cosmos Health at 0.01 subject to Rule 16b-3 | ||
Grigorios Siokas over six months ago Acquisition by Grigorios Siokas of 60000 shares of Cosmos Health at 0.8301 subject to Rule 16b-3 | ||
Georgios Terzis over a year ago Acquisition by Georgios Terzis of 51485 shares of Cosmos Health subject to Rule 16b-3 | ||
Grigorios Siokas over a year ago Purchase by Grigorios Siokas of 6712 shares of Cosmos Health | ||
Ziegler Manfred over a year ago Cosmos Health exotic insider transaction detected | ||
Georgios Terzis over a year ago Acquisition by Georgios Terzis of 100000 shares of Cosmos Health subject to Rule 16b-3 |
Cosmos Health Notable Stakeholders
A Cosmos Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cosmos Health often face trade-offs trying to please all of them. Cosmos Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cosmos Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Grigorios Siokas | Chairman of the Board, CEO, CFO | Profile | |
| Demetrios Demetriades | Secretary, Director | Profile | |
| Georgios Terzis | Chief Officer | Profile | |
| Pavlos Ignatiades | Chief Officer | Profile | |
| Nikolaos Bardakis | Chief Officer | Profile |
About Cosmos Health Management Performance
The success or failure of an entity such as Cosmos Health often depends on how effective the management is. Cosmos Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cosmos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cosmos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.33) | |
| Return On Capital Employed | (0.52) | (0.50) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.51) | (0.49) |
Cosmos Health Workforce Analysis
Traditionally, organizations such as Cosmos Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cosmos Health within its industry.Cosmos Health Manpower Efficiency
Return on Cosmos Health Manpower
| Revenue Per Employee | 434K | |
| Revenue Per Executive | 10.7M | |
| Net Loss Per Employee | 150.8K | |
| Net Loss Per Executive | 3.7M | |
| Working Capital Per Employee | 99.9K | |
| Working Capital Per Executive | 2.5M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.